Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second booster.
about
Use of licensed vaccines for active immunization of the immunocompromised hostVariability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsPoor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody TitersAssessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease.
P2860
Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second booster.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@en
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@nl
type
label
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@en
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@nl
prefLabel
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@en
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@nl
P2093
P1476
Anti-pneumococcal antibody lev ...... e, and after a second booster.
@en
P2093
P304
P356
10.1016/S0022-3476(95)70119-2
P407
P577
1995-10-01T00:00:00Z